1. Home
  2. LGO vs IXHL Comparison

LGO vs IXHL Comparison

Compare LGO & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

LGO

Largo Inc.

HOLD

Current Price

$1.61

Market Cap

112.1M

Sector

N/A

ML Signal

HOLD

Logo Incannex Healthcare Inc.

IXHL

Incannex Healthcare Inc.

HOLD

Current Price

$0.17

Market Cap

97.6M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
LGO
IXHL
Founded
1988
2001
Country
Canada
Australia
Employees
N/A
N/A
Industry
Sector
Exchange
Nasdaq
Nasdaq
Market Cap
112.1M
97.6M
IPO Year
2007
2024

Fundamental Metrics

Financial Performance
Metric
LGO
IXHL
Price
$1.61
$0.17
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$3.40
N/A
AVG Volume (30 Days)
2.2M
6.4M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$12,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$53.91
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.85
$0.11
52 Week High
$2.70
$1.66

Technical Indicators

Market Signals
Indicator
LGO
IXHL
Relative Strength Index (RSI) 60.40 25.04
Support Level $1.22 $0.17
Resistance Level $1.93 $0.42
Average True Range (ATR) 0.15 0.02
MACD -0.00 -0.01
Stochastic Oscillator 52.76 11.49

Price Performance

Historical Comparison
LGO
IXHL

About LGO Largo Inc.

Largo Inc is committed to the production and supply of high-quality vanadium products. The company is also focused on the advancement of renewable energy storage solutions through Largo Clean Energy and its vanadium redox flow battery technology. The Company is engaged in the mining, exploration, and development of mineral properties, predominantly in Brazil, through which it produces and supplies vanadium products VPURE Flake, VPURE+ Flake, and VPURE+ Powder. The company has operating segments: sales & trading, mine properties, which generates key revenue, corporate, exploration and evaluation properties, Clean Energy, and Largo Physical Vanadium.

About IXHL Incannex Healthcare Inc.

Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.

Share on Social Networks: